Get the Stockscreener App
1.60
4.19%
-0.07
After Hours:
1.55
-0.05
-3.13%
Cerus Corp stock is traded at $1.60, with a volume of 2.31M.
It is down -4.19% in the last 24 hours and up +35.59% over the past month.
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
See More
Previous Close:
$1.67
Open:
$1.68
24h Volume:
2.31M
Relative Volume:
1.83
Market Cap:
$306.72M
Revenue:
$156.37M
Net Income/Loss:
$-37.49M
P/E Ratio:
-7.619
EPS:
-0.21
Net Cash Flow:
$-47.77M
1W Performance:
+1.91%
1M Performance:
+35.59%
6M Performance:
+29.03%
1Y Performance:
-7.51%
1-Day Range:
$1.515
$1.68
1-Week Range:
$1.515
$1.70
52-Week Range:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Name
Cerus Corp
Sector
Industry
Phone
(925) 288-6000
Address
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.60 | 320.14M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-24 | Initiated | Craig Hallum | Buy |
| Jan-20-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-17-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-08-20 | Resumed | BTIG Research | Buy |
| Jun-16-20 | Resumed | Cantor Fitzgerald | Overweight |
| Feb-26-20 | Initiated | BTIG Research | Buy |
| Nov-13-19 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-28-19 | Initiated | Stifel | Buy |
| Aug-23-19 | Resumed | Stephens | Overweight |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Overweight |
| Dec-08-17 | Resumed | BTIG Research | Neutral |
| Jul-07-16 | Resumed | Cantor Fitzgerald | Buy |
| Dec-17-15 | Downgrade | Wedbush | Outperform → Neutral |
| May-02-14 | Reiterated | MLV & Co | Buy |
| Apr-24-13 | Reiterated | Cantor Fitzgerald | Buy |
| Mar-15-13 | Reiterated | MLV & Co | Buy |
| Apr-17-12 | Initiated | Cantor Fitzgerald | Buy |
| Feb-29-12 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-10-11 | Reiterated | MLV & Co | Buy |
| Jun-03-11 | Initiated | Wedbush | Outperform |
| Mar-04-11 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-09-10 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-26-09 | Upgrade | Avondale | Mkt Perform → Mkt Outperform |
View All
Cerus Corp Stock (CERS) Latest News
Wealth Enhancement Advisory Services LLC Acquires 27,092 Shares of Cerus Corporation $CERS - Defense World
Cerus Corporation stock trend forecastJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
What indicators show strength in Cerus CorporationMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Can a trend reversal in Cerus Corporation lead to recoveryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Visualizing Cerus Corporation stock with heatmapsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Cerus (NASDAQ:CERS) - MarketBeat
What’s the recovery path for long term holders of Cerus CorporationJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
Cerus Corporation (NASDAQ:CERS) Short Interest Update - MarketBeat
What Fibonacci levels say about Cerus Corporation reboundJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
What is the fair value estimate for Cerus Corporation (CU2) stock in 2025Quarterly Market Summary & High Return Stock Watch Alerts - newser.com
Can Cerus Corporation stock sustain market leadershipQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Will Cerus Corporation stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
What analysts say about Cerus Corporation CU2 stockCup and Handle Formations & Free Stay Ahead With Picks - earlytimes.in
What momentum indicators show for Cerus Corporation stockJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Is Cerus Corporation CU2 a good long term investmentTechnical Analysis Insights & High Profit Investment Ideas - earlytimes.in
Cerus Corporation CU2 Stock Analysis and ForecastAutomated Trading Signals & Best Stocks For Explosive Growth - earlytimes.in
What drives Cerus Corporation stock priceGap Up/Gap Down Analysis & High Return Trading Tips - earlytimes.in
What recovery options are there for Cerus CorporationMarket Trend Summary & Daily Momentum Trading Reports - newser.com
Cerus And 2 Other Promising Penny Stocks To Watch - simplywall.st
Cerus Corp Stock (CERS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cerus Corp Stock (CERS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):